ArticleJTO clinical and research reports2024

Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315).

Frank Griesinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.